The global laparoscopic devices market size was valued at USD 5.94 billion in 2018 and is anticipated to expand at a CAGR of 6.6% over the forecast period. Increase in number of patients suffering from gall bladder problem, crohn’s diseases,ulcerative colitis, diverticulitis and obesity are few factors driving the market.Laparoscopy is a minimally invasive technique used for performing surgeries, such as bariatric, gynecologic, and gall bladder surgery.
In laparoscopic surgical procedure, surgeons use incision of 0.5-1 cm, which is known as port. During the procedure, special camera and specialized instrument is passed through the trocars. This technique transmits images on the high-resolution video monitors in the operating room. These images include abdominal part of human body, which need to be operated through the surgery. Such surgeries allow surgeons to operate using smaller incision with efficacy and safety as compared to the traditional open surgery, which involves pain and risks to the patient.
Increasing prevalence of diseases, such as colorectal cancer, will also drive the market. Colorectal cancer includes symptoms, such as constipation, diarrhea, blood in feces, blood coming from rectum, and lump in the abdomen. Its treatment is based on several factors including the cancer location, size, and stage. Most common treatment, which surgeons recommend depending upon patient’s condition, is laparoscopic surgical treatment. This treatment is used to reduce the risk of cancer, which involves resection of bowel containing malignant tumors.
In addition, increasing cases of obesity and urological diseases are expected to contribute to the market growth. Bariatric surgeries are performed to treat obesity. Such surgeries lead to weight loss by restricting the amount of food storage in stomach. The most common bariatric surgeries are gastric bypass, adjustable gastric band, sleeve gastrectomy and Biliopancreatic (BPD) diversion with the duodenal switch. According to the American Society for Metabolic and Bariatric Surgery, in 2017, in U.S., 228,000 bariatric surgeries were performed.
Robot-assisted devices is expected to be the fastest-growing segment during the forecast period owing to factors, such as new product launches and improved patient care services. Such devices enhance the capabilities to overcome challenges in sterility, safety, and adaption. In 2000, the first robot-assisted surgical device, da Vinci surgery system by Intuitive Surgical, was approved by the U.S. FDA. It was designed to improve the feature and enhance the capabilities of the system. Its upgraded technology helps surgeons to operate using small incisions. Thus, new product developments and approvals by the regulatory authorities are driving the segment growth.
Energy systems led the market owing to increased electro surgeries. It’s a surgical technique in which tissue is heated using high-frequency current devices. Energy systems involve various energy sources, such as laser, ultrasound, electricity, and argon gas. New product development is also driving the segment growth. For example, Olympus surgical energy system THUNDERBEAT, which is a highly versatile instrument designed to integrates ultrasonic energy for improved dissection and rapid tissue cutting. It optimizes and standardizes the entire workflow, shortens operating time, and increases safety. It also allows surgeons to grasp and bluntly dissect tissue without switching instrument each time.
Bariatric surgery is the fastest-growing application segment over the forecast period owing to factors, such as increasing number of patients suffering from high Blood Pressure (BP) due to obesity will drive the segment.
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), surgeons use any one of the three surgical bariatric procedures, such as laparoscopic adjustable gastric band, gastric sleeve, and gastric bypass, to accomplish weight loss treatment for treatment of obesity. Rising geriatric population and cases of obesity across the globe are the major factors driving the segment growth.
North America dominated the market and is expected to witness substantial growth even during the forecast years due to increasing prevalence of colorectal cancer and obesity and increasing awareness about laparoscopic devices treatment. Moreover, quick adoption of technologically advanced products, such as energy systems, in the region is expected to drive the market. Increasing reimbursements for innovations in devices for improved quality of vision and treatment procedure is also positively affecting the laparoscopic devices market growth.
Asia Pacific is expected to witness the highest CAGR over the forecast period due to increasing number of patients suffering from atherosclerosis and high BP. Moreover, increasing cases of obesity have also boosted the demand for surgeries, such as gastric bypass, gastrectomy and gastric banding, thereby driving the market growth.
The major players in the industry comprise Medtronic PLC; Karl Storz GmbH; Stryker Corp.; Johnson and Johnson Services, Inc.; CONMED Corp.; and Olympus Corp. These companies focus on new product launch, technological advancements, and mergers and acquisitions to maintain their industry positions. For instance, Medtronic launched its composite mesh for surgical laparoscopic and open ventral hernia repair for improved visualization of anatomy during mesh placement over the hernia defect.
Base year for estimation
Actual estimates/Historical data
2015 - 2017
2019 - 2026
Revenue in USD Million and CAGR from 2018 to 2026
North America, Europe, Asia Pacific, Latin America, and MEA
U.S., Canada, U.K., Germany, France, Italy, Spain, Russia, Japan, China, India, Australia, South Korea, Singapore, Mexico, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, and UAE
Revenue, competitive landscape, growth factors, and trends
15% free customization scope (equivalent to 5 analysts working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2015 to 2026. For the purpose of this study, Grand View Research has segmented the global laparoscopic devices market report on the basis of product, application, and region:
Product Outlook (Revenue, USD Million, 2015 - 2026)
Hand Access Instruments
Robot Assisted Systems
Application Outlook (Revenue, USD Million, 2015 - 2026)
Regional Outlook (Revenue, USD Million, 2015 - 2026)
Middle East & Africa (MEA)
b. The global laparoscopic devices market size was valued at USD 6,311.0 million in 2019 and is expected to reach USD 6,710.7 million in 2020.
b. The global laparoscopic devices market is expected to grow at a compound annual growth rate of 6.6% from 2019 to 2026 to reach USD 9,915.0 million by 2026.
b. North America dominated the laparoscopic devices market with a share of 33.9% in 2019. This is attributable to increasing incidence of colorectal cancer, Crohn’s disease, technological advancements, and presence of key players in the region.
b. Key companies operating in the market are Medtronic PLC; Karl Storz GmbH; Stryker Corp.; Johnson and Johnson Services, Inc.; CONMED Corp.; and Olympus Corp.
b. Key factors that are driving the market growth include increasing number of patients suffering from gallstones, obesity, rectal prolapse, and severe gastroesophageal reflux disease syndrome.
Avail customized purchase options to meet your exact research needs:
Get your queries resolved from an industry expert.
Design an exclusive study to serve your research needs.
A testimonial for service in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.